Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2026-03-09 @ 8:18 AM
Study NCT ID:
NCT00662818
Status:
COMPLETED
Last Update Posted:
2018-10-19
First Post:
2008-04-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Telcagepant (MK-0974) Treatment of Migraine in Participants With Stable Vascular Disease (MK-0974-034)
Sponsor:
Merck Sharp & Dohme LLC
Organization: